Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haoyao Ruan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Speech Technology|April 3, 2023
Plain-to-clear speech video conversion for enhanced intelligibilityShubam Sachdeva, Haoyao Ruan, Ghassan Hamarneh, et al.
Journal of Comparative Effectiveness Research|April 4, 2024
Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancerAlessandria Struebing, Chelsea McKibbon, Haoyao Ruan, et al.
Advances in Therapy|July 25, 2022
Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple MyelomaJianming He, Heather Berringer, Bart Heeg, et al.
Advances in Therapy|July 3, 2024
Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate CancerMaria De Santis, Sara Martínez Breijo, Paul Robinson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Speech Technology|April 3, 2023
Plain-to-clear speech video conversion for enhanced intelligibilityShubam Sachdeva, Haoyao Ruan, Ghassan Hamarneh, et al.
Journal of Comparative Effectiveness Research|April 4, 2024
Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancerAlessandria Struebing, Chelsea McKibbon, Haoyao Ruan, et al.
Advances in Therapy|July 25, 2022
Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple MyelomaJianming He, Heather Berringer, Bart Heeg, et al.
Advances in Therapy|July 3, 2024
Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate CancerMaria De Santis, Sara Martínez Breijo, Paul Robinson, et al.
Pageof 1